WWP
EDIT icon

WR Wealth Planners’s Editas Medicine EDIT Stock Holding History

WR Wealth Planners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$4.03K Hold
3,175
– – ﹤0.01% 737
2024
Q3 		$10.8K Buy
3,175
+1,500
+90% +$6.53K ﹤0.01% 613
2024
Q2 		$7.82K Sell
1,675
-400
-19% -$2.26K ﹤0.01% 644
2024
Q1 		$15.4K Buy
+2,075
New +$17.2K ﹤0.01% 505
2023
Q4 		– Sell
-2,375
Closed -$18.5K – 370
2023
Q3 		$18.5K Hold
2,375
– – 0.01% 442
2023
Q2 		$19.5K Hold
2,375
– – 0.01% 441
2023
Q1 		$17.2K Buy
+2,375
New +$21.1K 0.01% 448

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

WR Wealth Planners's EDIT Position: Q4 2024 in Review

WR Wealth Planners held its Editas Medicine (EDIT) position steady in Q4 2024 at 3,175 shares worth $4.03K. The position accounts for ﹤0.01% of the portfolio, ranked #737.

WR Wealth Planners first reported a position in EDIT in Q1 2023 and has held it in 7 quarters since. The position peaked at $19.5K in Q2 2023. 207 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • WR Wealth Planners held 3,175 shares of Editas Medicine worth $4.03K as of Q4 2024.
  • WR Wealth Planners left its Editas Medicine share count unchanged in Q4 2024.
  • Editas Medicine made up ﹤0.01% of WR Wealth Planners's portfolio in Q4 2024, its #737 holding.
  • WR Wealth Planners first reported a position in Editas Medicine in Q1 2023 and has held it in 7 quarters since.
  • WR Wealth Planners's Editas Medicine position peaked at $19.5K in Q2 2023.
  • 207 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on WR Wealth Planners's 13F filing for Q4 2024, filed 5 Feb 2025.